warns that this therapy might cause neuronal death in the substantia nigra (SN) and could predispose individuals to hyperkinetic movement disorders and seizures. Hatzipetros et al. conclude that ...

describing a study in which researchers recorded dopamine and serotonin levels in the substantia nigra pars reticulata of patients with Parkinson’s disease undergoing DBS surgery. Disclaimer ...